Skip to content

Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions

Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03167723
Enrollment
193
Registered
2017-05-30
Start date
2017-05-08
Completion date
2021-12-20
Last updated
2023-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Tube Size, Empyema, Hemopneumothorax; Traumatic, Hemothorax

Keywords

Chest tube size, Hemothorax, Empyema

Brief summary

Traumatic hemothorax and hemopneumothorax are common diagnoses which are typically treated by placement of a chest tube. 28-32 Fr chest tubes have previously been shown equivalent to 36-40 Fr chest tubes for the non-emergent drainage of hemothorax. A smaller study has found 14 Fr pigtails had less pain than larger tubes but was not powered to compare outcomes. We seek to perform a prospective randomized trial that is adequately powered comparing efficacy of 14 Fr thal tubes to 28 Fr chest tubes for non-emergent drainage of hemothorax and hemopneumothorax. Additionally, we will employ maximal barrier precautions for all chest tube insertions and compare empyema rates to our historical controls.

Interventions

DEVICEChest tube placement

Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Investigator masked to outcomes data.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient is admitted to the trauma service. * The patient has a hemothorax and/or or hemopneumothorax, requiring thoracostomy tube placement. * Thoracostomy tube placement is able to be performed or witnessed by an investigator listed on the study. * The patient has not had a chest tube in the past year. * The patient is \>18 years of age. * In the event the patient is decisionally impaired, consent will be obtained from the individual's legally authorized representative (LAR) or from the individual's healthcare power of attorney (HPA). * In the instance of reversible impairment, initial consent would be obtained from the LAR/HPA and the patient will be approached for consent once he/she is deemed mentally competent by the care provider.

Exclusion criteria

* The patient is incarcerated * The patient is known to be pregnant * The patient is \< 18 years of age * The patient is hemodynamically unstable, requiring emergent chest tube placement (in \<10 minutes from evaluation).

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention90 daysNumber of Participants with Retained hemothorax requiring an additional intervention, either video-assisted thoracoscopic surgery (VATS) or additional thoracostomy tube placement.

Secondary

MeasureTime frameDescription
Number of Participants Stratified by Length of Hospitalization Stay90 daysNumber of weeks spent in hospital
Change in Subjective Pain Scores From Baseline at 90 Days90 daysAssessed with 0-10 numeric pain rating scale - the higher the number, the more severe the pain
Hemodynamic Stability Post-insertion90 daysdetermined by vital signs: temperature, heart rate, blood pressure, oxygen saturation (Systolic Blood Pressure \<90mm Hg)
Initial Drainage From Chest Tube at 5 Minutes5 MinutesMilliliters of chest tube drainage at 5 minutes
Duration of Chest Tube Placement.90 daysNumber of days with chest tube placement
Time to Radiographic Resolution of Pneumothorax/Hemothorax/Hemopneumothorax90 daysNumber of days until radiographic resolution of pneumothorax/hemothorax/hemopneumothorax
Recurrent Pneumothorax/Hemothorax/Hemopneumothorax After Tube Removal90 daysNumber of Participants with Recurrent pneumothorax/hemothorax/hemopneumothorax after tube removal
Readmission for Chest Tube Related Complications90 daysNumber of Participants readmitted for chest tube related complications
Tube Specific Complications: Air Leak, Tube Malposition, & Tube Migration90 daysNumber of Tube specific complications: Air leak, tube malposition, & tube migration

Countries

United States

Participant flow

Pre-assignment details

Excluded (n=84) Hemodynamic instability (n=36) Chest tube placed at outside facility (n=12) Multiple chest tube placement (n=10) Declined to participate (n=1) Not meet inclusion criteria (n=6) Other reasons (n=19)

Participants by arm

ArmCount
28 French Chest Tube for Hemothorax
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
55
14 French Chest Tube for Hemothorax
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
54
Total109

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation46

Baseline characteristics

Characteristic28 French Chest Tube for Hemothorax14 French Chest Tube for HemothoraxTotal
Age, Continuous49.9 years46.5 years49 years
Injury Severity Score - score that ranges from 3 (least) to 75 (most) injured17 units on a scale18 units on a scale17 units on a scale
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
17 Participants15 Participants32 Participants
Sex: Female, Male
Male
38 Participants39 Participants77 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 552 / 54
other
Total, other adverse events
0 / 550 / 54
serious
Total, serious adverse events
0 / 550 / 54

Outcome results

Primary

Number of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention

Number of Participants with Retained hemothorax requiring an additional intervention, either video-assisted thoracoscopic surgery (VATS) or additional thoracostomy tube placement.

Time frame: 90 days

ArmMeasureValue (NUMBER)
28 French Chest Tube for HemothoraxNumber of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention51 Number of Participants
14 French Chest Tube for HemothoraxNumber of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention48 Number of Participants
p-value: 0.036Farrington-Manning
Secondary

Change in Subjective Pain Scores From Baseline at 90 Days

Assessed with 0-10 numeric pain rating scale - the higher the number, the more severe the pain

Time frame: 90 days

ArmMeasureValue (MEDIAN)
28 French Chest Tube for HemothoraxChange in Subjective Pain Scores From Baseline at 90 Days0 units on a scale
14 French Chest Tube for HemothoraxChange in Subjective Pain Scores From Baseline at 90 Days0 units on a scale
Secondary

Duration of Chest Tube Placement.

Number of days with chest tube placement

Time frame: 90 days

ArmMeasureValue (MEDIAN)
28 French Chest Tube for HemothoraxDuration of Chest Tube Placement.3.9 days
14 French Chest Tube for HemothoraxDuration of Chest Tube Placement.3.9 days
Secondary

Hemodynamic Stability Post-insertion

determined by vital signs: temperature, heart rate, blood pressure, oxygen saturation (Systolic Blood Pressure \<90mm Hg)

Time frame: 90 days

ArmMeasureValue (NUMBER)
28 French Chest Tube for HemothoraxHemodynamic Stability Post-insertion2 Number of Participants
14 French Chest Tube for HemothoraxHemodynamic Stability Post-insertion1 Number of Participants
Secondary

Initial Drainage From Chest Tube at 5 Minutes

Milliliters of chest tube drainage at 5 minutes

Time frame: 5 Minutes

ArmMeasureValue (MEDIAN)
28 French Chest Tube for HemothoraxInitial Drainage From Chest Tube at 5 Minutes150 mL
14 French Chest Tube for HemothoraxInitial Drainage From Chest Tube at 5 Minutes100 mL
Secondary

Number of Participants Stratified by Length of Hospitalization Stay

Number of weeks spent in hospital

Time frame: 90 days

ArmMeasureGroupValue (NUMBER)
28 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay3 Weeks7 Number of Participants
28 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay1 Week20 Number of Participants
28 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay> or = 4 Weeks5 Number of Participants
28 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay2 Weeks19 Number of Participants
14 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay> or = 4 Weeks12 Number of Participants
14 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay3 Weeks6 Number of Participants
14 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay2 Weeks15 Number of Participants
14 French Chest Tube for HemothoraxNumber of Participants Stratified by Length of Hospitalization Stay1 Week15 Number of Participants
Secondary

Readmission for Chest Tube Related Complications

Number of Participants readmitted for chest tube related complications

Time frame: 90 days

ArmMeasureValue (NUMBER)
28 French Chest Tube for HemothoraxReadmission for Chest Tube Related Complications9 participants
14 French Chest Tube for HemothoraxReadmission for Chest Tube Related Complications4 participants
Secondary

Recurrent Pneumothorax/Hemothorax/Hemopneumothorax After Tube Removal

Number of Participants with Recurrent pneumothorax/hemothorax/hemopneumothorax after tube removal

Time frame: 90 days

ArmMeasureValue (NUMBER)
28 French Chest Tube for HemothoraxRecurrent Pneumothorax/Hemothorax/Hemopneumothorax After Tube Removal5 participants
14 French Chest Tube for HemothoraxRecurrent Pneumothorax/Hemothorax/Hemopneumothorax After Tube Removal1 participants
Secondary

Time to Radiographic Resolution of Pneumothorax/Hemothorax/Hemopneumothorax

Number of days until radiographic resolution of pneumothorax/hemothorax/hemopneumothorax

Time frame: 90 days

ArmMeasureValue (MEDIAN)
28 French Chest Tube for HemothoraxTime to Radiographic Resolution of Pneumothorax/Hemothorax/Hemopneumothorax0.5 days
14 French Chest Tube for HemothoraxTime to Radiographic Resolution of Pneumothorax/Hemothorax/Hemopneumothorax1 days
Secondary

Tube Specific Complications: Air Leak, Tube Malposition, & Tube Migration

Number of Tube specific complications: Air leak, tube malposition, & tube migration

Time frame: 90 days

ArmMeasureValue (NUMBER)
28 French Chest Tube for HemothoraxTube Specific Complications: Air Leak, Tube Malposition, & Tube Migration7 Ocurrences
14 French Chest Tube for HemothoraxTube Specific Complications: Air Leak, Tube Malposition, & Tube Migration5 Ocurrences

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026